Worldwide Healthcare Trust PLC Stock

Equities

WWH

GB00BN455J50

Investment Trusts

Market Closed - London S.E. 11:35:23 2024-06-21 EDT 5-day change 1st Jan Change
358 GBX +0.85% Intraday chart for Worldwide Healthcare Trust PLC +0.28% +15.11%

Financials

Sales 2023 34.33M 43.41M 59.46M Sales 2024 235M 297M 407M Capitalization 1.83B 2.31B 3.17B
Net income 2023 -8M -10.12M -13.85M Net income 2024 201M 254M 348M EV / Sales 2023 56.7 x
Net cash position 2023 3M 3.79M 5.19M Net cash position 2024 4.86M 6.14M 8.41M EV / Sales 2024 7.76 x
P/E ratio 2023
-229 x
P/E ratio 2024
9.75 x
Employees -
Yield 2023
1%
Yield 2024
0.84%
Free-Float 90.16%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.85%
1 week+0.28%
Current month+3.77%
1 month+2.14%
3 months+8.65%
6 months+18.35%
Current year+15.11%
More quotes
1 week
351.02
Extreme 351.02
358.00
1 month
336.50
Extreme 336.5
358.50
Current year
307.85
Extreme 307.8485
358.50
1 year
286.00
Extreme 286
358.50
3 years
282.00
Extreme 282
392.50
5 years
215.95
Extreme 215.9515
396.50
10 years
126.50
Extreme 126.5008
396.50
More quotes
Members of the board TitleAgeSince
Director/Board Member 70 16-02-14
Director/Board Member 55 18-06-06
Director/Board Member - 22-08-31
More insiders
Date Price Change Volume
24-06-21 358 +0.85% 2,034,415
24-06-20 355 +1.00% 1,209,022
24-06-19 351.5 -0.99% 1,646,393
24-06-18 355 -0.42% 1,374,061
24-06-17 356.5 -0.14% 767,676

Delayed Quote London S.E., June 21, 2024 at 11:35 am

More quotes
Worldwide Healthcare Trust PLC is a specialist investment trust. The Company invests in the global healthcare sector with the objective of achieving a high level of capital growth. It invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It invests up to 10% of the portfolio, at the time of acquisition, in unquoted securities. It invests approximately 50% of the portfolio in larger companies, and at over 20% of the portfolio in smaller companies. It may invest over 5% of the portfolio, at the time of acquisition, in debt instruments, convertibles and royalty bonds issued by pharmaceutical and biotechnology companies. It may invest over 30% of the portfolio in companies under sectors, such as healthcare equipment and supplies, and healthcare providers and services. Its alternative investment fund manager is Frostrow Capital LLP. OrbiMed Capital LLC is its portfolio manager.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.58
Average target price
-
Consensus